Risk factors for irinotecan-induced hepatotoxicity: a retrospective cohort study
{{output}}
Background: Irinotecan is a potent chemotherapeutic agent used as a neoadjuvant in colorectal cancer liver metastasis and significantly enhances five-year survival rates. Recently, irinotecan-associated hepatotoxicity was a signi... ...